The OvuSense2 is a fertility monitoring program designed to help women increase their chances of getting pregnant. Developed by VIO HealthTech Ltd, this program offers two sensor options: the OvuFirst sensor for those with regularday cycles, and the OvuCore sensor for women with more variable cycles or conditions like PCOS. What sets OvuSense2 apart is its true medical device status, backed by 3 clinical studies, 9 publications, and 10 patents. It is the only fertility monitoring solution with class II regulatory approval in the USA, Europe, Canada, and Australia.

OvuSense2 accurately tracks ovulation and confirms its occurrence, providing a full 8-day fertile window at the start of each cycle. This maximizes the chances of pregnancy, making it an ideal choice for women with regular or irregular cycles, as well as those with PCOS. The program consists of a vaginal sensor (OvuCore) or a skin-worn sensor (OvuFirst) and the OvuSense App. The app charts and messages provide all the necessary information to help women identify when they ovulate, giving them the best chances of conceiving. Additionally, the OvuSense App allows for data sharing with doctors and family members, making it a comprehensive and convenient fertility monitoring solution.